Literature DB >> 1081963

Platelet hyperaggregation and increased plasma level of Von Willebrand factor in diabetics with retinopathy.

D Bensoussan, S Levy Toledano, P Passa, J Caen, J Caniver.   

Abstract

In 18 insulin-dependent diabetics (6 without retinopathy, 6 with proliferative retinopathy and 6 with proliferative retinopathy treated by hypophysectomy) matched for age and duration of diabetics, in vitro haemostasis was studied using ADP induced platelet aggregation, ristocetin induced platelet aggregation which allows von Willebrand factor (VIII VWF) assay, and determination of antihemophilic factor procoagulant activity (VII AHF). Using gel filtration-isolated platelets, the ADP induced hyperaggregation previously reported in diabetics with severe retinopathy untreated by hypophysectomy appeared to be related to a platelet and not a plasma factor; the normal results of thrombin induced aggregation suggests that the presumed abnormal platelet factor is related to the platelet plasma membrane. High level of plasma VII VWF was observed in diabetics with proliferative retinopathy while the VII AHF level was within normal limits.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081963     DOI: 10.1007/bf00422396

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  21 in total

1.  INCREASED ACTIVIY OF "ANTI-WILLEBRAND FACTOR" IN DIABETIC PLASMA.

Authors:  A E ODEGAARD; A J HELLEM
Journal:  Thromb Diath Haemorrh       Date:  1964-04-15

2.  [New diagnostic method in hemophilia; determination of antihemophilic factors A and B].

Authors:  J P SOULIER; M J LARRIEU
Journal:  Sang       Date:  1953

3.  Aggregation of human gel-filtered platelets. Requirement of apyrase and proteins.

Authors:  S Levy-Toledano; F Rendu; P Besson; J Caen
Journal:  Rev Eur Etud Clin Biol       Date:  1972-05

4.  An abnormal platelet glycoprotein pattern in three cases of Glanzmann's thrombasthenia.

Authors:  A T Nurden; J P Caen
Journal:  Br J Haematol       Date:  1974-10       Impact factor: 6.998

5.  [Study of platelet aggregation during diabetic retinopathy. Influence of hypophysectomy].

Authors:  P Passa; D Bensoussan; S Levy-Toledano; J Caen; J Canivet
Journal:  Atherosclerosis       Date:  1974 Mar-Apr       Impact factor: 5.162

6.  Ristocetin--a new tool in the investigation of platelet aggregation.

Authors:  M A Howard; B G Firkin
Journal:  Thromb Diath Haemorrh       Date:  1971-10-31

7.  Platelet adhesiveness, plasma fibrinogen and factor 8 levels in diabetes mellitus.

Authors:  E E Mayne; J M Bridges; J A Weaver
Journal:  Diabetologia       Date:  1970-08       Impact factor: 10.122

8.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

9.  Human glomerular basement membrane: chemical alteration in diabetes mellitus.

Authors:  P G Beisswenger; R G Spiro
Journal:  Science       Date:  1970-05-01       Impact factor: 47.728

10.  Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.

Authors:  H J Weiss; L W Hoyer; F R Rickles; A Varma; J Rogers
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

View more
  21 in total

1.  Diabetologia--25 years.

Authors:  C Hellerström
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

2.  Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage?

Authors:  M Greaves; C Pickering; G Knight; A J Boulton; J Ball; J D Ward; F E Preston
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

3.  Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function.

Authors:  M E Plater; I Ford; M T Dent; F E Preston; J D Ward
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

4.  Diabetes and Platelet Response to Low-Dose Aspirin.

Authors:  Mohammed E Al-Sofiani; Lisa R Yanek; Nauder Faraday; Brian G Kral; Rasika Mathias; Lewis C Becker; Diane M Becker; Dhananjay Vaidya; Rita R Kalyani
Journal:  J Clin Endocrinol Metab       Date:  2018-12-01       Impact factor: 5.958

5.  Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetic microvascular disease.

Authors:  S B Solerte; F Piovella; C Viola; G C Schianca; G Gamba; M Fioravanti; E Ferrari
Journal:  Acta Diabetol Lat       Date:  1985 Jul-Sep

6.  The evolution of diabetic retinopathy.

Authors:  E V Kohner
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

Review 7.  Endothelial cell function in diabetic microangiopathy.

Authors:  M Porta; M La Selva; P Molinatti; G M Molinatti
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

8.  Studies of retinopathy and the plasma co-factor of platelet hyperaggregation in type 1 (insulin-dependent) diabetic children.

Authors:  R D Levin; H C Kwaan; J G Dobbie; C L Fetkenhour; H S Traisman; C Kramer
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

9.  Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion.

Authors:  G E Trope; G D Lowe; B M McArdle; J T Douglas; C D Forbes; C M Prentice; W S Foulds
Journal:  Br J Ophthalmol       Date:  1983-03       Impact factor: 4.638

10.  Platelet shape change abnormalities in diabetic retinopathy.

Authors:  M Porta; P Hilgard; E M Kohner
Journal:  Diabetologia       Date:  1980-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.